The patent recognizes Newton’s sophisticated approach to providing critical soft tissue data that helps orthopaedic surgeons execute a total knee replacement with precision
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent #11,278,338 for the Newton Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way.
“The patent allowance supports the uniqueness of Newton and its ability to maintain a force-controlled environment regardless of the joint gap through antagonist sub-mechanisms,” said Laurent Angibaud, Vice President of Advanced Surgical Technologies at Exactech. “While initially dedicated to total knee arthroplasty, Newton has the potential to be applied to other joints where proper soft tissue management is of paramount importance.”
The patent recognizes Newton’s sophisticated approach to providing critical soft tissue data that helps orthopaedic surgeons execute a total knee replacement with precision. Newton is unique in that it captures active balance data through the entire arc of motion with the patella in place and seamlessly integrates with ExactechGPS to allow surgeons the ability to visualize a predictive plan through quantifiable insights. This results in a powerful system that is designed for a dynamic, patient-specific and reproducible outcome.
“This recognition is a significant achievement for Exactech,” said Darin Johnson, Exactech President and CEO. “The patent not only protects the commercial potential of the Newton Knee, but it also demonstrates our unwavering commitment to protecting innovation around our entire Active Intelligence suite of technologies.”
The Newton Knee is in pilot release with limited launch planned for later this year.
Source: Company Press Release